🎧Coming this fall to headphones near you… all-new episodes of #DowntheGradient.
Join Toney Jacobson and Adine Mitrani for practical conversations with leading experts on how AI is being developed, governed and commercialized.
Subscribe: https://t.co/ztOWyhnfwy
Eric Ball and Todd Gregorian spoke about their defense of the Brown Jug’s “Buckeye Tears” beer in its trademark dispute with Ohio State University on PLI’s pro bono podcast. Listen here: https://t.co/CFMurYDYGr
#TrademarkLitigation#ProBono
San Francisco and LA, we’re coming for you!
As the sole legal sponsor of Tech Week, we’re excited to bring you a lineup of events across both cities. Check them out here: https://t.co/XiGi5ScKPw
#SFTechWeek#LATechWeek#FenwickAtTechWeek
Meet Anna Uhls: former FBI counsel, ex-Uber in-house lawyer, and now counsel in Fenwick's Congressional Investigations & White Collar practices.
She shares why oversight is heating up for tech and life sciences companies and what drew her to Fenwick 👇
https://t.co/AQGiFYLgUx
The Federal Circuit just raised the bar for patent owners seeking pre-suit damages: You now have to plead your licensees’ marking compliance too.
Read what it means for both patentees and defendants: https://t.co/W4oy84Sv9w
#PatentLitigation#FederalCircuit
Biotech IPOs are back — 21 deals, $7.85B raised in 2026, the strongest year since 2021.
Fenwick's Amanda Rose and Ryan Mitteness talk with Mergermarket about who's winning (Phase 2/3, strong data) and who's still on the sidelines.
https://t.co/tUgSPOMONr
#Biotech#IPO
The California Air Resources Board has provided supplemental guidance for the first round of greenhouse gas emissions reporting, requiring large companies to submit reports on their GHG emissions data: https://t.co/hfWoSNiVhP
#Corporate#ESG
Biotech IPO demand is strong, but the path to success is paved with key indicators like strong clinical data and a clear regulatory pathway, corporate partners Amanda Rose and Chelsea Anderson told Axios Pro in a featured Q&A.
Learn more: https://t.co/o1wFV755Z7
#Biotech#IPO
Congratulations to Michael Dicke and David Hayes, named Lawyers of the Year in 2027 Best Lawyers! They’re among 101 Fenwick attorneys recognized this year, including 55 Ones to Watch.
Congratulations to all our recognized attorneys: https://t.co/5oOf5EbS8i
Find all the advisers on @OpenRouter's sale to @stripe in David Marcus' Deal Diary. @ClearyGottlieb's Charles Allen and @Orrick's Joshua Pollick are counsel to OpenRouter, and @FenwickWest's Ken Myers represents Stripe. https://t.co/rM9GLguLlP
Sudan, Syria, and Iran all saw major sanctions and export control shifts this summer. Our latest alert breaks down what's new: https://t.co/8rMKx3Yi9w
#Sanctions#ExportControls
Fenwick corporate partner and UCLA Law alum Michael Brown was recently featured in their alumni spotlight to give insight on how his time at UCLA prepared him to guide the transactions that are shaping the innovation economy: https://t.co/JCP981huCM
#MandA#Corporate
Prediction markets are creating new avenues for employees, contractors, and other key partners to unlawfully bet on nonpublic clinical and regulatory data--and generate a host of new risks for their employers.
Learn more:
https://t.co/rFKXxi1n9Z
#Biotech#LifeSciences
What if attention is all you need—to claim? The IP & Technology Law Journal has re-published Claire Baek's paper looking at a strategic way to draft patent claims involving transformer-based AI systems.
https://t.co/j974bhKJdI
#AI#Patents
Jon McMichael was named a Law360 Rising Star, and he spoke with the publication about using his engineering background as part of his legal work representing innovative tech and life sciences companies: https://t.co/wauYrXlbEP
#LegalAwards#PatentLitigation
Fenwick is proud to represent Stripe, a financial infrastructure platform for businesses, in its pending acquisition of OpenRouter, an AI model gateway and routing platform.
Learn more: https://t.co/w2CeIBHCEp
#MandA#AI
Fenwick is proud to represent iRhythm Holdings, Inc., a digital health care company focused on creating trusted solutions that detect, predict and prevent disease, in its $287.5 million pending acquisition of Vital Connect, Inc: https://t.co/tSTQLizQks
Congratulations to River AI on its $1.1 billion Seed and Series A funding.
Fenwick is proud to represent the personalized AI company, which will use the funds to advance its mission of building powerful personal AI that knows you and works for you: https://t.co/RAFmMbuFXU